PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Penn researchers demonstrate efficacy of non-Hodgkin's lymphoma vaccine

2011-10-19
(Press-News.org) PHILADELPHIA — An experimental vaccine developed by researchers at the University of Pennsylvania's schools of Medicine and Veterinary Medicine is the first veterinary cancer vaccine of its kind that shows an increase in survival time for dogs with spontaneous non-Hodgkin's lymphoma. The work shows for the first time the feasibility and therapeutic efficacy of this alternative cell-based vaccine, which could be employed in the treatment of a number of different cancer types.

The research was conducted by Nicola Mason, assistant professor of medicine at Penn Vet; Robert H. Vonderheide, associate professor of hematology and oncology at the Perelman School of Medicine; and Karin U. Sorenmo, associate professor of oncology at Penn Vet. Erika Krick, Beth Overley and Thomas P. Gregor of Penn Vet and Christina M. Coughlin of the School of Medicine also contributed to the research.

Their work was published in the open access journal PLOS ONE.

The team recruited dogs that were brought to Penn's Matthew J. Ryan Veterinary Hospital with newly diagnosed non-Hodgkin's lymphoma to receive the experimental vaccine following standard induction chemotherapy and confirmation of clinical remission. The goal of the study was to determine whether the vaccine would prevent or prolong time to a relapse, a common scenario in both humans and dogs with NHL.

"We vaccinated dogs, which were in clinical remission following chemotherapy, three times," Mason said. "We then tracked them over several years to see if the vaccine would prevent relapse and would prolong overall survival.

"We found that, although the vaccinated dogs still relapsed with clinical disease when they were treated with rescue chemotherapy, they had significantly increased overall survival times when compared to an unvaccinated control group. Some of these dogs are still alive and cancer free more than three years later.

"The results with these dogs indicate that our immunotherapy and rescue chemotherapy appear to act synergistically to prevent a second relapse – a phenomenon that has been previously recognized in human patients treated with other types of immunotherapy," she said.

Previous cell based vaccines have utilized genetically engineering dendritic cells — which are part of the immune system — to stimulate immune responses against cancers. Similar to using weakened viruses in traditional vaccines, scientists load these cells with tumor proteins and inject the cells back into the patient's body. Such cell-based vaccines are already being used to treat prostate cancer in humans, but engineering these cells is expensive and time consuming. Furthermore, patients must also endure long, leukapheresis sessions in which the necessary dendritic cells are harvested from their blood.

The Penn team hypothesized that another kind of immune cell, B-cells, could work just as well under the right conditions. Unlike dendritic cells, many B-cells can be grown from a small blood sample, removing the requirement for leukapheresis.

Mason's team made the vaccine by culturing B-cells from the blood taken from the dogs with NHL. These cells were then loaded with RNA that had been isolated from the patient's own tumor.

The results were impressive.

"Though vaccinated and unvaccinated dogs relapsed with clinical disease at the same time, 40 percent of vaccinated dogs that relapsed experienced long-term survival after a second round of chemotherapy; only 7 percent of unvaccinated dogs that relapsed and were treated with the same rescue chemotherapy protocol survived long term," Mason said. "Furthermore, when the vaccinated long-term survivors did eventually die, they showed no evidence of lymphoma on full necropsy."

While the molecular mechanisms responsible for these observed synergistic effects are currently unknown, Mason believes that the vaccine-primed immune system may be boosted by the effects of rescue chemotherapy leading to long term second remissions.

Though the increases in long-term survival are already unprecedented and the proof-of-concept for B-cell-based cancer vaccines represents a step forward in cell-based vaccine development, future research could have even more exciting results.

"These dogs just received three doses of vaccine, three weeks apart. If we kept boosting the immune system in this way by vaccination, perhaps the dogs would not relapse in the first place" Mason said.

Work is now underway to streamline B-cell vaccine generation and initiate further clinical trials aimed at optimizing this novel cell-based approach.

### This work was supported by the National Institutes of Health, Alliance for Cancer Gene Therapy, Onyx and Breezy Foundation, Barry and Savannah Poodle Memorial Fund, Mari Lowe Comparative Oncology Center, Immunobiology Program of the Abramson Cancer Center at the University of Pennsylvania and Oncology Research Fund at the Veterinary Hospital of the University of Pennsylvania.


ELSE PRESS RELEASES FROM THIS DATE:

Congressman Fortenberry's New GI Bill Promises Veteran Entrepreneurship And Jobs Creation; Bill Authored By Service Disabled Veteran

2011-10-19
On October 13, with little fanfare, Congressman Jeff Fortenberry (NE-1) introduced the Veterans Entrepreneurial Transition (VET) Act of 2011, a landmark new GI Bill that would allow veterans to use their already budgeted educational benefits earned under existing GI Bills, to start up new small businesses. The VET Act (H.R. 3167) is a GI Bill aimed at addressing the unacceptably high veteran unemployment rate, as well as to help quickly re-build a new generation of veteran-owned small business enterprises across America as the backbone of new job creation. This GI ...

The political effects of existential fear

2011-10-19
Why did the approval ratings of President George W. Bush— who was perceived as indecisive before September 11, 2001—soar over 90 percent after the terrorist attacks? Because Americans were acutely aware of their own deaths. That is one lesson from the psychological literature on "mortality salience" reviewed in a new article called "The Politics of Mortal Terror." The paper, by psychologists Florette Cohen of the City University of New York's College of Staten Island and Sheldon Solomon of Skidmore College, appears in October's Current Directions in Psychological Science, ...

African-Americans more likely to donate kidney to family member

2011-10-19
WINSTON-SALEM, N.C. – Oct. 18, 2011 – Family matters, especially when it comes to African-Americans and living kidney donation. In a study conducted at Wake Forest Baptist Medical Center, researchers found that African-Americans donate almost exclusively to family members for living kidney transplants, as compared to Caucasians. The retrospective study, published in the September/October online issue of the journal Clinical Transplantation, compared medical records of all former successful kidney donors at Wake Forest Baptist between Jan. 1, 1991, and Dec. 31, 2009. The ...

How hemp got high: Canadian scientists map the cannabis genome

2011-10-19
A team of Canadian researchers has sequenced the genome of Cannabis sativa, the plant that produces both industrial hemp and marijuana, and in the process revealed the genetic changes that led to the plant's drug-producing properties. Jon Page is a plant biochemist and adjunct professor of biology at the University of Saskatchewan. He explains that a simple genetic switch is likely responsible for the production of THCA, or tetrahydrocannabinolic acid, the precursor of the active ingredient in marijuana. "The transcriptome analysis showed that the THCA synthase gene, ...

More evidence that allergies may help in fighting brain tumors

2011-10-19
PROVIDENCE, R.I. [Brown University] — A study published online Oct. 18 in the Journal of the National Cancer Institute provides some new but qualified support for the idea that the immune system's response to allergies may reduce the risk of developing deadly brain tumors. People with somewhat elevated blood levels of immunoglobulin E (IgE), antibodies that carry out the body's immune response to allergens, were significantly less likely to develop gliomas, and those who did survived somewhat longer, than those with clinically normal IgE levels, according to the study ...

VISTA finds new globular star clusters and sees right through the heart of the Milky Way

VISTA finds new globular star clusters and sees right through the heart of the Milky Way
2011-10-19
The dazzling globular cluster called UKS 1 dominates the right-hand side of the first of the new infrared images from ESO's VISTA survey telescope at the Paranal Observatory in Chile. But if you can drag your gaze away, there is a surprise lurking in this very rich star field — a fainter globular cluster that was discovered in the data from one of VISTA's surveys. You will have to look closely to see the other star cluster, which is called VVV CL001: it is a small collection of stars in the left half of the image. But VVV CL001 is just the first of VISTA's globular discoveries. ...

Casey Storage Solutions Acquires Self Storage Facility in Pawtucket RI

2011-10-19
Casey Real Estate Investment, LLC and Casey Property Management, LLC are pleased to announce the acquisition of a 72,000 square foot self storage facility located at 201 Concord Street in Pawtucket RI. The new store will operate under the brand name, Casey Storage Solutions (http://www.caseystoragesolutions.com). The property will be managed by Casey Property Management, LLC. This acquisition brings Casey Storage Solutions' holdings to eight self storage properties consisting of over 450,000 square feet and over 3,500 self storage units. Casey Storage Solutions operates ...

Polymer characterization 'tweezers' turn Nobel theory into benchtop tool

Polymer characterization tweezers turn Nobel theory into benchtop tool
2011-10-19
(UC Santa Barbara –) Researchers at UC Santa Barbara have developed a new and highly efficient way to characterize the structure of polymers at the nanoscale – effectively designing a routine analytical tool that could be used by industries that rely on polymer science to innovate new products, from drug delivery gels to renewable bio-materials. Professor Omar Saleh and graduate student Andrew Dittmore of the UCSB Materials department have successfully measured the structure and other critical parameters of a long, string-like polymer molecule – polyethylene glycol, or ...

Can breastfeeding reduce pain in preterm infants?

2011-10-19
Philadelphia, PA, October 19, 2011 – Poorly managed pain in the neonatal intensive care unit has serious short- and long-term consequences, causing physiological and behavioral instability in preterm infants and long-term changes in their pain sensitivity, stress arousal systems, and developing brains. In a study published in the November issue of PAIN®, researchers report that breastfeeding during minor procedures mitigated pain in preterm neonates with mature breastfeeding behaviors. Currently, pain associated with minor procedures such as pricking for blood tests ...

InTopic Media Helps Business Owners Work Smart with Pay-Per Click Advertising

2011-10-19
Mention pay-per-click advertising to an Internet business owner and you are likely to be met with a roll of the eyes. Pay-per-click is often the elephant in the marketing office: everyone knows it's there, but no one really wants to acknowledge it. There is good reason. Some business owners ventured into "PPC" and quickly exited with low-performing results and unwanted expense. Jayson Hahn of InTopic Media understands the business owner's pain. "Pay per click advertising can generate fast traffic, and affordably, when implemented wisely. Pay-per-click ...

LAST 30 PRESS RELEASES:

NHS urged to offer single pill to all over-50s to prevent heart attacks and strokes

Australian researchers call for greater diversity in genomics

The pot is already boiling for 2% of the world’s amphibians: new study

A new way to predict cancer's spread? Scientists look at 'stickiness' of tumor cells

Prehistoric bone tool ‘factory’ hints at early development of abstract reasoning in human ancestors

Study: Vaping does not help US tobacco smokers quit

Insect populations are declining — and that is not a good thing

Scientists discover genes to grow bigger tomatoes and eggplants

Effects of combining coronary calcium score with treatment on plaque progression in familial coronary artery disease

Cancer screening 3 years after the onset of the COVID-19 pandemic

Trajectories of sleep duration, sleep onset timing, and continuous glucose monitoring in adults

Sports gambling and drinking behaviors over time

For better quantum sensing, go with the flow

Toxic environmental pollutants linked to faster aging and health risks in US adults

Jerome Morris voted AERA President-Elect; key members elected to AERA Council

Study reveals how agave plants survive extreme droughts

Aligning Science Across Parkinson’s (ASAP) launches a second funding opportunity to accelerate novel tool development to advance Parkinson's disease research

New study: Eating mangos daily shown to improve insulin sensitivity and blood glucose control

Highly radioactive nuclear waste – how to keep it from oblivion

Generations ‘sync’ up in rural ‘glades’ to boost technology use for health

Unveiling the mechanism of maintenance of replication and transcription in mitochondria

Pioneering research into brain cancer is awarded the world’s largest brain research prize, The Brain Prize

Concrete evidence: Japanese buildings absorb 14% of cement production's carbon footprint

New study examines how physics students perceive recognition

For some, childhood adversity can promote resilience to anxiety disorders

A sustainable iron catalyst for water oxidation in renewable energy

Cloud–radiation feedbacks found to be key to the diverse tropical pacific warming projections

Body image perceptions take shape from early childhood, psychologists reveal

Can long-term use of anti-inflammatory medications prevent dementia?

Review supports introducing small amounts of food allergens during early childhood

[Press-News.org] Penn researchers demonstrate efficacy of non-Hodgkin's lymphoma vaccine